Guidelines & Consensus Guidance
CVD Prevention
2021: ESC Guidelines on cardiovascular disease prevention in clinical practice https://pubmed.ncbi.nlm.nih.gov/34458905/ 2019: ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines https://pubmed.ncbi.nlm.nih.gov/30894318/ 2013: ACC/AHA Lifestyle management to prevent CVD…
read more »
FH
2021: Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia https://pubmed.ncbi.nlm.nih.gov/33309206/ 2021: Update of the Brazilian Guideline for Familial Hypercholesterolemia https://pubmed.ncbi.nlm.nih.gov/34709306/ 2019: NICE. Familial hypercholesterolaemia: identification and management https://www.guidelines.co.uk/genetic-conditions/nice-fh-guideline/453843.article 2018: Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018 https://pubmed.ncbi.nlm.nih.gov/30527143/ 2017: Guidelines…
read more »
Dyslipidaemia management
2021: Lipid Measurements in the Management of Cardiovascular Diseases: NLA Scientific Statement https://www.lipid.org/sites/default/files/files/JACL%201734(3).pdf 2021: Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. https://pubmed.ncbi.nlm.nih.gov/33781847/ 2021: Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease—European Atherosclerosis Society/European…
read more »
